日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study

NTAA预后模型在接受经动脉化疗栓塞治疗的BCLC B期肝细胞癌中的应用及验证:一项回顾性多中心队列研究

Chen, Shuanggang; Shen, Lujun; Lin, Letao; Qi, Han; Chang, Boyang; Zeng, Qi; Lu, Linbin; Huang, Jingjun; Tan, Hongtong; Cao, Fei; Xie, Lin; Huang, Tao; Wu, Ying; Wen, Chunyong; Wang, Yujia; Tang, Ruizhi; Li, Chen; Zheng, Guanglei; Nuerhashi, Gulijiayina; Fan, Weijun

Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell Non-Hodgkin lymphoma

对B细胞非霍奇金淋巴瘤的临床特征、生物学特性和免疫微环境中铜凋亡相关基因进行全面研究

Liu, Chengcheng; Shao, Ruonan; Li, Xiaoqing; Li, Yiran; Tian, Zhi; Zhou, Fenling; Chen, Lu; Liu, Jiajun; Chang, Boyang; Liu, Wenjian; Tang, Hailin

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study

肝动脉灌注化疗联合乐伐替尼和PD-1抑制剂治疗伴门静脉癌栓的肝细胞癌动静脉分流:一项回顾性队列研究

Liu, Guanxiong; Zhu, Duo; He, Quansheng; Zhou, Churen; He, Li; Li, Zhengran; Jiang, Zaibo; Huang, Mingsheng; Chang, Boyang; Wu, Chun

Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis

改良经动脉化疗栓塞术与载药微球经动脉化疗栓塞术作为单发肝细胞癌初始治疗的临床疗效:倾向评分匹配分析

Chang, Boyang; Zhou, Churen; Liu, Chengcheng; Mu, Luwen; Huang, Mingsheng; Bai, Mingjun

Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma

三种E2F靶向相关基因特征可用于预测肝细胞癌的预后、免疫特征和药物敏感性

Zhang, Baozhu; Chang, Boyang; Wang, Lu; Xu, Yuzhong

The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma

血清可溶性程序性死亡蛋白1 (sPD-1) 和可溶性程序性死亡配体1 (sPD-L1) 水平与肝细胞癌患者的相关性及预后价值

Chang, Boyang; Huang, Tao; Wei, Huajun; Shen, Lujun; Zhu, Duo; He, Wenjun; Chen, Qifeng; Zhang, Huihua; Li, Yunjian; Huang, Ruopan; Li, Wang; Wu, Peihong

Ultrasound Assessment of Muscle Injury Associated with Closed Limb Fracture

超声评估闭合性肢体骨折相关的肌肉损伤

Liu, Wenfen; Wang, Dong; Ouyang, Hui; Chen, Ningning; Chang, Boyang; Zhu, Qingtang; Li, Jiachun

Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data

基于时间序列数据的生存路径映射,对肝细胞癌患者进行动态预后预测

Shen, Lujun; Zeng, Qi; Guo, Pi; Huang, Jingjun; Li, Chaofeng; Pan, Tao; Chang, Boyang; Wu, Nan; Yang, Lewei; Chen, Qifeng; Huang, Tao; Li, Wang; Wu, Peihong

High number of PD-1 positive intratumoural lymphocytes predicts survival benefit of cytokine-induced killer cells for hepatocellular carcinoma patients

肿瘤内PD-1阳性淋巴细胞数量高预示着细胞因子诱导的杀伤细胞可使肝细胞癌患者获益。

Chang, Boyang; Shen, Lujun; Wang, Kefeng; Jin, Jietian; Huang, Tao; Chen, Qifeng; Li, Wang; Wu, Peihong

A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection

纳入肿瘤浸润深度的预后列线图用于预测舌鳞状细胞癌R0切除术后患者的长期总生存期

Chang, Boyang; He, Wenjun; Ouyang, Hui; Peng, Jingwen; Shen, Lujun; Wang, Anxun; Wu, Peihong